Value Added Medicines / Scientific, Regulatory and IP Analysis
Price available after dates are announced
TRAINING TIMES
- TBDVienna
- TBDLondon
- TBDNew York
- TBDLos Angeles
LEARNING OBJECTIVES
The concept of value in the health care environment
The concept of value in the health care environment
Analyze the market before embarking on an added value strategy
Analyze the market before embarking on an added value strategy
Create viable business models in different markets
Create viable business models in different markets
Is repositioning a high-risk strategy – when could it be suitable for your company?
Is repositioning a high-risk strategy – when could it be suitable for your company?
How to differentiate a generic product
How to differentiate a generic product
Select the right route to drug approval
Select the right route to drug approval
What type of products to stay away from because of clinical barriers
What type of products to stay away from because of clinical barriers
An in-depth scientific discussion of different mechanisms that could lead to an added value product
An in-depth scientific discussion of different mechanisms that could lead to an added value product
Case studies of Formulation patents – successes and failures
Case studies of Formulation patents – successes and failures
Consequences of market switch from Brand to INN generics
Consequences of market switch from Brand to INN generics
KEY TOPICS
Innovative Generic Business Development A concept of value in health care environment Market Access for Value Added Medicines Drug Repositioning / Repurposing
Scientific and Technological solutions for Value Added Medicines Formulation patents: successes and failures 
